reglab/statecodes huggingface dataset:
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Optometry › Board of Optometry - General Rules › Part 2 - EDUCATIONAL PROGRAMS, EXAMINATIONS, LICENSES AND CERTIFICATIONS › Section R. 338.321 - Professional optometric degree program; approval standards

Current through Vol. 24-12, July 15, 2024
Rule 21.
(1) The
					 board approves and adopts by reference the standards of ACOE set forth in the
					 publication entitled, "Accreditation Council on Optometric Education Policy and
					 Procedure Manual," published June 2022, which provides for the accreditation of
					 professional optometric degree programs. A copy of the Accreditation Manual of
					 ACOE is available free of charge from the AOA's website at
https://www.aoa.org/AOA/Documents/Education/ACOE/ACOE_Policy_and_Procedure_Manual_07_2021.pdf
.
					 Printed copies also are available for inspection and distribution at a cost of
					 10 cents per page from the Bureau of Professional Licensing, Department of
					 Licensing and Regulatory Affairs, Ottawa Building, 611 West Ottawa, P.O. Box
					 30670, Lansing, Michigan 48909.
(2)
					 A professional optometric degree program accredited by ACOE is considered
					 approved by the board.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Optometry › Board of Optometry - General Rules › Part 2 - EDUCATIONAL PROGRAMS, EXAMINATIONS, LICENSES AND CERTIFICATIONS › Section R. 338.322 - Examination approval and adoption; limitations; passing score

Current through Vol. 24-12, July 15, 2024
Rule 22.
(1) The
					 board approves and adopts the NBEO examinations developed, administered, and
					 scored by the NBEO or its successor.
(2) An applicant applying for licensure shall
					 have achieved a passing score on all of the following parts of the NBEO
					 examinations:
(a) Part I.
(b) Part II, including a passing score on the
					 TMOD examination imbedded in Part II.
(c) Part III.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Optometry › Board of Optometry - General Rules › Part 2 - EDUCATIONAL PROGRAMS, EXAMINATIONS, LICENSES AND CERTIFICATIONS › Section R. 338.323 - Initial licensure by examination

Current through Vol. 24-12, July 15, 2024
Rule 23. An applicant for initial licensure by
						examination shall submit a completed application on the form provided by the
						department, together with the requisite fee. In addition to meeting the
						requirements of the code and the administrative rules promulgated under the
						code, an applicant shall satisfy all of the following requirements:
(a) Have graduated from a professional
					 optometric degree program approved by the board under
					 R 338.321, and hold the doctor of
					 optometry degree.
(b) Have achieved
					 a passing score on parts I, II, and III of the NBEO examinations approved under
					 R 338.322, including a passing score
					 on the TMOD examination imbedded in part II.
(c) Have achieved a minimum scaled score of
					 75 on the optometry jurisprudence examination developed and administered by the
					 department or an entity approved by the department.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Optometry › Board of Optometry - General Rules › Part 2 - EDUCATIONAL PROGRAMS, EXAMINATIONS, LICENSES AND CERTIFICATIONS › Section R. 338.327 - Limited licenses

Current through Vol. 24-12, July 15, 2024
Rule 27.
(1) The
					 board may issue an educational limited license, under section
					 16182(2)(a) of
					 the code, MCL
					 333.16182, to an individual that
					 meets the requirements of the code and the administrative rules promulgated
					 under the code and who meets both of the following:
(a) Has graduated from a board-approved
					 professional optometric degree program, or who will graduate from the program
					 not more than 3 months after applying for an educational limited
					 license.
(b) Is enrolled in a
					 postgraduate course of study or participates in a residency program that is
					 offered by the United States Department of Veterans Affairs or an institution
					 approved by the ACOE.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Optometry › Board of Optometry - General Rules › Part 2 - EDUCATIONAL PROGRAMS, EXAMINATIONS, LICENSES AND CERTIFICATIONS › Section R. 338.329 - Certification to administer topical ocular diagnostic pharmaceutical agents; application; qualifications; adoption of standards; prohibitions

Current through Vol. 24-12, July 15, 2024
Rule 29.
(1) An
					 applicant for certification to administer a topical ocular diagnostic
					 pharmaceutical agent in the practice of optometry shall submit a completed
					 application, on a form provided by the department, together with the requisite
					 fee. In addition to meeting the other requirements of the code and the
					 administrative rules promulgated under the code, an applicant shall satisfy all
					 of the following requirements:
(a)
					 Successfully complete a course of study in general and clinical pharmacology
					 related to the practice of optometry as required in section
					 17412(2)(a) of
					 the code, MCL
					 333.17412. The course of study
					 must include passing an examination on general and ocular pharmacology. The
					 applicant has successfully completed the required course of study when the
					 applicant has been granted the credit hours designated for the course of study
					 by the teaching institution where the course is offered.
(b) Establish a board-approved emergency
					 plan, under section
					 17412(2)(d) of
					 the code, MCL
					 333.17412, for the management and
					 referral of patients who experience any adverse drug reaction. To be
					 board-approved, the emergency plan must include all of the following:
(i) Patient instructions related to an
					 adverse drug reaction.
(ii) A
					 referral procedure for a patient reporting an adverse drug reaction.
(iii) The names and contact information of
					 not less than 3 physicians, clinics, or hospitals to whom the patient reporting
					 an adverse drug reaction may be referred.
(iv) A documentation procedure for the
					 information to be included in the patient's medical record regarding the report
					 of an adverse drug reaction.
(c) Successfully complete a course in CPR as
					 required by section
					 17412(2)(c) of
					 the code, MCL
					 333.17412, approved by the
					 department of health and human services, and offered or approved by any of the
					 following:
(i) The Red Cross.
(ii) The American Heart
					 Association.
(iii) An accredited
					 hospital.
(iv) An organization or
					 institution comparable to those identified in paragraphs (i) to (iii) of this
					 subdivision.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Optometry › Board of Optometry - General Rules › Part 2 - EDUCATIONAL PROGRAMS, EXAMINATIONS, LICENSES AND CERTIFICATIONS › Section R. 338.330 - Certification to administer and prescribe therapeutic pharmaceutical agents; application; qualifications

Current through Vol. 24-12, July 15, 2024
Rule 30.
(1) An
					 applicant for certification to administer and prescribe a therapeutic
					 pharmaceutical agent in the practice of optometry shall submit a completed
					 application, on a form provided by the department, together with the requisite
					 fee. In addition to meeting the other requirements of the code and the
					 administrative rules promulgated under the code, an applicant shall satisfy all
					 of the following requirements:
(a) Meet the
					 certification requirements to administer diagnostic pharmaceutical agents under
					 R 338.315.
(b) Successfully complete a course of study
					 relating to the didactic and clinical use of therapeutic pharmaceutical agents
					 as required in section
					 17435(2)(b) of
					 the code, MCL
					 333.17435.
(c) Establish a board-approved management
					 plan that complies with section
					 17435(2)(c) of
					 the code, MCL
					 333.17435.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Optometry › Board of Optometry - General Rules › Part 3 - CONTINUING EDUCATION AND LICENSE RENEWAL › Section R. 338.331 - License renewal; continuing education, requirements, limitations

Current through Vol. 24-12, July 15, 2024
Rule 31.
(1) An
					 applicant for license renewal shall satisfy the requirements of the
					 R 338.7001 to
					 R 338.7005 and accumulate not less
					 than 40 continuing education hours approved by the board under
					 R 338.332 or
					 R 338.333 during the 2 years
					 immediately preceding the date of application for renewal.
(2) An applicant for license renewal who
					 holds certification to administer topical ocular diagnostic pharmaceutical
					 agents or certification to administer and prescribe therapeutic pharmaceutical
					 agents, or both, shall do both of the following:
(a) Accumulate not less than 20 hours of
					 board-approved continuing education in pharmacological management of ocular
					 conditions. The 20 required hours are part of, and not in addition to, the 40
					 hours required in subrule (1) of this rule. A continuing education program that
					 falls within COPE categories listed in
					 R 338.332(7)(n)(iii)(A) to
					 (I) meets the requirements of this
					 subdivision.
(b) Hold a valid CPR
					 certificate issued by any of the following:
(i) The Red Cross.
(ii) The American Heart
					 Association.
(iii) An accredited
					 hospital.
(iv) An organization or
					 institution comparable to those identified in paragraphs (i) to (iii) of this
					 paragraph.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Rescinded - Board of Osteopathic - Continuing Education

Current through Vol. 24-12, July 15, 2024
DEPARTMENT OF LICENSING AND REGULATORY
				  AFFAIRS
DIRECTOR'S OFFICE
OSTEOPATHIC MEDICINE AND SURGERY - GENERAL
				  RULES
CONTINUING EDUCATION
By Authority conferred on the director of the department of
					 licensing and regulatory affairs by sections 16145, 16148, 16204, 17533, and
					 17548 of 1978 PA 368, MCL 333.16145, 333.16148, 333.16204, 333.17533, and
					 333.17548 and Executive Reorganization Order Nos. 1996-1, 1996-2, 2003-1, and
					 2011-4, MCL 330.3101, 445.2001, 445.2011, and
					 445.2030
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 1 - GENERAL PROVISIONS › Section R. 338.111 - Definitions

Current through Vol. 24-12, July 15, 2024
Rule 11.
(1) As
					 used in these rules:
(a) "Board" means the
					 Michigan board of osteopathic medicine and surgery created under section 17521
					 of the code, MCL 333.17521.
(b)
					 "Code" means the public health code, 1978 PA 368, MCL 333.1101 to
					 333.25211.
(c) "Department" means
					 the department of licensing and regulatory affairs.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 1 - GENERAL PROVISIONS › Section R. 338.114 - Telehealth

Current through Vol. 24-12, July 15, 2024
Rule 14.
(1) A
					 licensee shall obtain consent for treatment before providing a telehealth
					 service under section
					 16284 of the code, MCL
					 333.16284.
(2) A licensee shall maintain proof of
					 consent for telehealth treatment in the patient's up-to-date medical record and
					 satisfy section
					 16213 of the code, MCL
					 333.16213.
(3) A licensee providing a telehealth service
					 may prescribe a drug if the licensee is a prescriber acting within the scope of
					 the licensee's practice and in compliance with section
					 16285 of the code, MCL
					 333.16285, and if the licensee
					 does both of the following:
(a) Refers the
					 patient to a provider that is geographically accessible to the patient, if
					 medically necessary.
(b) Makes
					 himself or herself available to provide follow-up care services to the patient,
					 or to refer the patient to another provider, for follow-up
					 care.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 1 - GENERAL PROVISIONS › Section R. 338.115 - Code of ethics

Current through Vol. 24-12, July 15, 2024
Rule 15.
(1) The
					 standards of the American Osteopathic Association, 142 E. Ontario Street,
					 Chicago, IL 60611-2864 set forth in the "Code of Ethics," dated July 24, 2016,
					 which are available at no cost on the association's website at
https://osteopathic.org
, are
					 approved and adopted by reference.
(2) A licensee shall not violate the code of
					 ethics.
(3) Copies of the adopted
					 standards referenced in subrule (1) of this rule are available for inspection
					 and distribution at a cost of 10 cents per page from the Board of Osteopathic
					 Medicine and Surgery, Bureau of Professional Licensing, Department of Licensing
					 and Regulatory Affairs, 611 West Ottawa, P.O. Box 30670, Lansing, Michigan
					 48909.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 1 - GENERAL PROVISIONS › Section R. 338.117 - Prescribing of drugs by physician's assistants; procedures and protocols

Current through Vol. 24-12, July 15, 2024
Rule 17.
(1)
					 Under section 17548(3) and (4) of the code, MCL 333.17548, and under the terms
					 of a practice agreement, a physician's assistant may prescribe a drug,
					 including a controlled substance that is included in schedules 2 to 5 of part
					 72 of the code, MCL 333.7201 to 333.7231, subject to both of the following
					 requirements:
(a) If a physician's assistant
					 prescribes a drug, the physician's assistant's name must be used, recorded, or
					 otherwise indicated in connection with that prescription.
(b) If a physician's assistant prescribes a
					 drug that is included in schedules 2 to 5, the physician's assistant's DEA
					 registration number must be used, recorded, or otherwise indicated in
					 connection with that prescription.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 1 - GENERAL PROVISIONS › Section R. 338.119 - Delegation of prescribing controlled substances to an advanced practice registered nurse; limitation

Current through Vol. 24-12, July 15, 2024
Rule 19.
(1) A
					 physician may delegate the prescription of controlled substances listed in
					 schedules 2 to 5 of part 72 of the code, MCL
					 333.7201 to MCL
					 333.7231, to a registered nurse
					 who holds specialty certification under section
					 17210 of the code, MCL
					 333.17210, except for a nurse
					 anesthetist, if the delegating physician establishes a written authorization
					 that has all the following information:
(a)
					 The name, license number, and signature of the delegating physician.
(b) The name, license number, and signature
					 of the nurse practitioner, nurse midwife, or clinical nurse
					 specialist.
(c) The limitations or
					 exceptions to the delegation.
(d)
					 The effective date of the delegation.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 1 - GENERAL PROVISIONS › Section R. 338.120 - Training standards for identifying victims of human trafficking; requirements

Current through Vol. 24-12, July 15, 2024
Rule 20.
(1)
					 Under section
					 16148 of the code, MCL
					 333.16148, an individual seeking
					 licensure or that is licensed shall complete training in identifying victims of
					 human trafficking that satisfies the following standards:
(a) Training content must cover all the
					 following:
(i) Understanding the types and
					 venues of human trafficking in the United States.
(ii) Identifying victims of human trafficking
					 in health care settings.
(iii)
					 Identifying the warning signs of human trafficking in health care settings for
					 adults and minors.
(iv) Identifying
					 resources for reporting the suspected victims of human trafficking.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 2 - LICENSES › Section R. 338.121 - Accreditation standards for approval of osteopathic medical schools, postgraduate training programs, and institutions; adoption by reference

Current through Vol. 24-12, July 15, 2024
Rule 21.
(1) The
					 standards for accrediting osteopathic medical schools developed and adopted by
					 the American Osteopathic Association Commission on Osteopathic College
					 Accreditation, 142 E. Ontario Street, Chicago, Illinois 60611-2864, set forth
					 in the publication entitled "Accreditation of Colleges of Osteopathic Medicine:
					 COM Accreditation Standards," effective July 1, 2019, which are available at no
					 cost on the association's website at
https://osteopathic.org
, are approved and
					 adopted by reference. Any osteopathic school of medicine accredited by the
					 Commission on Osteopathic College Accreditation is approved.
(2) The standards of the American Osteopathic
					 Association Council on Postdoctoral Training, 142 E. Ontario Street, Chicago,
					 Illinois 60611-2864, set forth in the publication entitled "The Basic Documents
					 for Postdoctoral Training," effective July 1, 2020, which are available at no
					 cost on the association's website at
https://osteopathic.org
, are approved and
					 adopted by reference. Any osteopathic postgraduate training program accredited
					 by the American Osteopathic Association Council on Postdoctoral Training is
					 approved.
(3) The standards of the
					 American Osteopathic Association Council on Osteopathic Postdoctoral Training
					 Institutions, 142 E. Ontario Street, Chicago, Illinois 60611-2864, set forth in
					 the publication entitled "OPTI Accreditation Handbook," effective March 2014,
					 which are available at no cost on the association's website at
https://osteopathic.org
, are
					 approved and adopted by reference. Any osteopathic institution accredited by
					 the American Osteopathic Association Council on Osteopathic Postdoctoral
					 Training Institutions is approved.
(4) The standards for approval of a
					 postgraduate training program developed and adopted by the Accreditation
					 Council for Graduate Medical Education, 401 North Michigan Avenue, Suite 2000,
					 Chicago, Illinois 60611, set forth in the publication entitled "ACGME Common
					 Program Requirements," effective July 1, 2021, which are available at no cost
					 on the council's website at
https://www.acgme.org
, are approved and
					 adopted by reference. Any medical postgraduate training program accredited by
					 the Accreditation Council for Graduate Medical Education is approved.
(5) Copies of the standards adopted by
					 reference in this rule are available for inspection and distribution at a cost
					 of 10 cents per page from the Board of Osteopathic Medicine and Surgery, Bureau
					 of Professional Licensing, Licensing and Regulatory Affairs, 611 West Ottawa
					 Street, P.O. Box 30670, Lansing, Michigan 48909.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 2 - LICENSES › Section R. 338.123 - Licensure by examination

Current through Vol. 24-12, July 15, 2024
Rule 23. An applicant for a doctor of osteopathic
						medicine and surgery license shall satisfy the requirements of the code and the
						rules promulgated under the code, as well as all the following
						requirements:
(a) Provide the required
					 fee and a completed application on a form provided by the department.
(b) Provide proof verifying completion of a
					 degree from a school of osteopathic medicine that satisfies the standards under
					 R
					 338.121(1).
(c) Provide proof verifying passing scores on
					 all levels of the Comprehensive Osteopathic Medical Licensing Examination of
					 the United States (COMLEX-USA) adopted under
					 R 338.129 and provide proof verifying
					 satisfaction of all the requirements under
					 R 338.129.
(d) Provide proof verifying completion of a
					 minimum of 1 year of postgraduate clinical training in a program that satisfies
					 either of the following requirements:
(i) A
					 postgraduate training program that satisfies the requirements under
					 R 338.121(2) at a
					 training institution that satisfies the requirements under
					 R
					 338.121(3).
(ii) A postgraduate training program approved
					 under R
					 338.121(4).
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 2 - LICENSES › Section R. 338.125 - Licensure by endorsement

Current through Vol. 24-12, July 15, 2024
Rule 25.
(1) An
					 applicant for a doctor of osteopathic medicine and surgery license by
					 endorsement shall satisfy the requirements of the code and the rules
					 promulgated under the code, as well as all the following requirements:
(a) Provide the required fee and a completed
					 application on a form provided by the department.
(b) Provide proof verifying the holding of a
					 current and full doctor of osteopathic medicine and surgery license in another
					 state or in a province of Canada.
(c) If the applicant is licensed as a doctor
					 of osteopathic medicine and surgery in a province in Canada, provide proof
					 verifying that the applicant completed the educational requirements in Canada
					 or in the United States at a school of osteopathic medicine that satisfies the
					 standards under R
					 338.121(1) for licensure as a doctor
					 of osteopathic medicine and surgery in Canada or in the United
					 States.
(d) Provide proof verifying
					 passing scores on all levels of the COMLEX-USA adopted under
					 R 338.129 and provide proof verifying
					 satisfaction of all the requirements under
					 R 338.129 for a doctor of osteopathic
					 medicine and surgery license in another state or in a province of Canada to
					 obtain licensure as a doctor of osteopathic medicine and surgery in another
					 state or in a province of Canada.
(e) Provide proof verifying completion of a
					 minimum of 1 year of postgraduate clinical training in a program that satisfies
					 either of the following requirements:
(i) A
					 postgraduate training program that satisfies the requirements under
					 R 338.121(2) at a
					 training institution that satisfies the requirements under
					 R
					 338.121(3).
(ii) A postgraduate training program approved
					 under R
					 338.121(4).
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 2 - LICENSES › Section R. 338.127 - Educational limited license

Current through Vol. 24-12, July 15, 2024
Rule 27.
(1) An
					 individual not eligible for a doctor of osteopathic medicine and surgery
					 license shall obtain an educational limited license before engaging in
					 postgraduate training.
(2) An
					 applicant for an educational limited license shall satisfy the requirements of
					 the code and the rules promulgated under the code, as well as all the following
					 requirements:
(a) Provide the required fee and
					 a completed application on a form provided by the department.
(b) Provide proof verifying that the
					 applicant has graduated or is expected to graduate within 3 months after the
					 date of the application from an osteopathic medical school that satisfies the
					 requirements under R
					 338.121(1).
(c) Provide proof verifying that the
					 applicant has been accepted into a postgraduate training program that satisfies
					 the requirements under
					 R 338.121(2) or
					 (4).
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 2 - LICENSES › Section R. 338.129 - Examination; adoption; passing scores; limitation on attempts; time limitations

Current through Vol. 24-12, July 15, 2024
Rule 29.
(1) The
					 COMLEX-USA, developed and administered by the National Board of Osteopathic
					 Medical Examiners (NBOME), is approved and adopted, and consists of the
					 following levels:
(a) COMLEX-USA Level
					 1.
(b) COMLEX-USA Level 2-Cognitive
					 Evaluation (Level 2-CE).
(c)
					 COMLEX-USA Level 2-Performance Evaluation (Level 2-PE) or a temporary
					 eligibility pathway approved by the NBOME.
(d) COMLEX-USA Level 3.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 2 - LICENSES › Section R. 338.133 - Relicensure

Current through Vol. 24-12, July 15, 2024
Rule 33.
(1) An
					 applicant whose doctor of osteopathic medicine and surgery license has lapsed
					 for less than 3 years preceding the date of application for relicensure may be
					 relicensed under section
					 16201(3) of
					 the code, MCL
					 333.16201, if the applicant
					 satisfies the requirements of the code and the rules promulgated under the
					 code, as well as all the following requirements:
(a) Provides the required fee and a completed
					 application on a form provided by the department.
(b) Provides proof verifying the completion
					 of not less than 150 hours of continuing education that satisfies the
					 requirements under R 338.141
					 during the 3 years immediately preceding the date of the application for
					 relicensure.
(c) Establishes good
					 moral character as that term is defined in, and determined under, 1974 PA 381,
					 MCL 338.41 to
					 338.47.
(d) An applicant who holds or has ever held a
					 license to practice osteopathic medicine and surgery shall establish all the
					 following requirements:
(i) Disciplinary
					 proceedings are not pending against the applicant.
(ii) If sanctions have been imposed against
					 the applicant, the sanctions are not in force when applying.
(iii) A previously held license was not
					 surrendered or allowed to lapse to avoid discipline.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 3 - CONTINUING EDUCATION › Section R. 338.141 - License renewals

Current through Vol. 24-12, July 15, 2024
Rule 41.
(1) An
					 applicant for renewal shall satisfy the requirements of the code and the rules
					 promulgated under the code.
(2) An
					 applicant for license renewal who has been licensed in the 3-year period
					 immediately preceding the application for renewal shall accumulate a minimum of
					 150 hours of continuing education credit in activities approved under
					 R 338.143 during the 3 years
					 immediately preceding the application for renewal.
(3) Submission of an application for renewal
					 constitutes the applicant's certification of compliance with the requirements
					 of this rule. The licensee shall maintain documentation of satisfying the
					 requirements of this rule for 4 years after the date of applying for license
					 renewal. Failure to satisfy this rule is a violation of section
					 16221(h) of
					 the code, MCL
					 333.16221.
(4) The department may select and audit a
					 sample of licensees who have renewed their license and request proof of
					 compliance with subrule (2) of this rule. If audited, a licensee shall provide
					 documentation as specified in
					 R 338.143.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Osteopathic Medicine and Surgery › Board of Osteopathic - Medicine and Surgery › Part 3 - CONTINUING EDUCATION › Section R. 338.143 - Acceptable continuing education; requirements; limitations

Current through Vol. 24-12, July 15, 2024
Rule 43.
(1) The
					 150 hours of continuing education credits required under
					 R 338.141 must satisfy the following
					 requirements, as applicable:
(a) Credit for a
					 continuing education program or activity that is identical or substantially
					 equivalent to a program or activity for which the licensee has already earned
					 credit during the renewal period cannot be granted.
(b) A minimum of 1 hour of continuing
					 education credit must be earned in medical ethics.
(c) For license renewals filed December 20,
					 2017 or later, a minimum of 3 hours of continuing education credit must be
					 earned in pain and symptom management under section
					 17533(2) of
					 the code, MCL
					 333.17533. At least 1 of the 3
					 hours must include controlled substances prescribing. Continuing education
					 hours in pain and symptom management may include, but are not limited to, any
					 of the following areas:
(i) Public health
					 burden of pain.
(ii) Ethics and
					 health policy related to pain.
(iii) Michigan pain and controlled substance
					 laws.
(iv) Pain
					 definitions.
(v) Basic sciences
					 related to pain including pharmacology.
(vi) Clinical sciences related to
					 pain.
(vii) Specific pain
					 conditions.
(viii) Clinical
					 physician communication related to pain.
(ix) Management of pain, including evaluation
					 and treatment and non-pharmacological and pharmacological management.
(x) Ensuring quality pain care and controlled
					 substances prescribing.
(xi)
					 Michigan programs and resources relevant to pain.
(d) A minimum of 60 continuing education
					 credits must be obtained through category 1 programs listed in subrule (2) of
					 this rule.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Pharmacy › Board of Pharmacy - General Rules › ADMINISTRATIVE HEARINGS › Section R. 338.486 - "Medical institution" and "pharmacy services" defined; pharmacy services in medical institutions

Current through Vol. 24-12, July 15, 2024
Rule 16.
(1) As
					 used in this rule:
(a) "Medical institution"
					 means a hospital, skilled nursing facility, county medical care facility,
					 nursing home, freestanding surgical outpatient facility, hospice, or other
					 health facility that is licensed or approved by the state, which directly or
					 indirectly provides or includes pharmacy services.
(b) "Pharmacy services" means the direct and
					 indirect patient care services for patients in a medical institution,
					 associated with the practice of pharmacy.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Pharmacy › Board of Pharmacy - General Rules › PHARMACY SERVICES IN MEDICAL INSTITUTIONS › Part 1 - GENERAL PROVISIONS › Section R. 338.503 - Prescription drugs and devices; return or exchange for resale prohibited

Current through Vol. 24-12, July 15, 2024
Rule 3.
(1)
						Prescription drugs or devices that have been dispensed and have left the
						control of the pharmacist must not be returned or exchanged for
						resale.
(2) This rule does not
						apply to any of the following:
(a) A pharmacy
						operated by the department of corrections or under contract with the department
						of corrections or a county jail, as provided in section 17766d of the code, MCL
						333.17766d.
(b) A pharmacy or
						charitable clinic that participates in the program for the utilization of
						unused prescription drugs, as provided in section 17775 of the code, MCL
						333.17775.
(c) A pharmacy or health
						facility that participates in the cancer drug repository program, as provided
						in section 17780 of the code, MCL 333.17780.
(d) Drugs returned when the wrong medication
						was dispensed to the patient or in the instance of a drug recall. Subject to
						R 338.486(7), in no
						instance may returned drugs be reused or returned to active stock.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Pharmacy › Board of Pharmacy - General Rules › PHARMACY SERVICES IN MEDICAL INSTITUTIONS › Part 1 - GENERAL PROVISIONS › Section R. 338.505 - Inspection of applicants and licensees

Current through Vol. 24-12, July 15, 2024
Rule 5.
(1)
						The board, board inspector, board agent, or an entity approved under
						R 338.532, may enter at reasonable
						times, any building, place, or facility that is owned or controlled by any
						applicant for, or holder of, a license to inspect to enable the board to
						determine if the applicant possesses the qualifications and competence for the
						license sought or to determine whether a license holder is and has been
						complying with the code and rules. The inspection must concern only matters
						relevant to the applicant's or license holder's practice of pharmacy,
						manufacturing, and wholesale distribution of drugs and devices saleable by
						prescription only.
(2) Inspections
						in subrule (1) of this rule must not extend to any of the following
						information, however, the following information is subject to a disciplinary
						investigation:
(a) Financial data.
(b) Purchasing data, other than shipment
						data, and the current and historical selling price of a drug.
(c) Personnel data, other than data as to the
						qualifications of personnel performing functions subject to the acts and rules
						enforced by the board.
(d) Research
						data, other than research data that confirms the appropriate use of controlled
						substances for research purposes, or research data for accountability for
						reconciliation of prescription drug inventories.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Pharmacy › Board of Pharmacy - General Rules › PHARMACY SERVICES IN MEDICAL INSTITUTIONS › Part 2 - PHARMACIST LICENSES › Section R. 338.511 - Training standards for identifying victims of human trafficking; requirements

Current through Vol. 24-12, July 15, 2024
Rule 11.
(1)
						Under section 16148 of the code, MCL
						333.16148, the individual seeking
						licensure or who is licensed shall have completed training in identifying
						victims of human trafficking that meets the following standards:
(a) Training content must cover all of the
						following:
(i) Understanding the types and
						venues of human trafficking in the United States.
(ii) Identifying victims of human trafficking
						in healthcare settings.
(iii)
						Identifying the warning signs of human trafficking in healthcare settings for
						adults and minors.
(iv) Identifying
						resources for reporting the suspected victims of human trafficking.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Pharmacy › Board of Pharmacy - General Rules › PHARMACY SERVICES IN MEDICAL INSTITUTIONS › Part 2 - PHARMACIST LICENSES › Section R. 338.513 - Educational limited license; application and renewal; practices

Current through Vol. 24-12, July 15, 2024
Rule 13.
(1)
						An applicant for an educational limited license shall submit to the department
						a completed application on a form provided by the department with the requisite
						fee. In addition to satisfying the requirements of sections 16174 and 17737 of
						the code, MCL
						333.16174 and
						333.17737, the applicant shall
						establish 1 of the following:
(a) That the
						applicant is actively enrolled in, or is within 180 days of completing, an
						approved educational program.
(b)
						That the applicant has received a FPGEC certification from the NABP Foreign
						Pharmacy Graduate Examination Committee, 1600 Feehanville Drive, Mount
						Prospect, Illinois, 60056,
https://nabp.pharmacy/programs/fpgec/
.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Pharmacy › Board of Pharmacy - General Rules › PHARMACY SERVICES IN MEDICAL INSTITUTIONS › Part 2 - PHARMACIST LICENSES › Section R. 338.515 - Internship requirements

Current through Vol. 24-12, July 15, 2024
Rule 15.
(1)
						An applicant for a pharmacist license shall acquire a minimum of 1,600
						internship hours, which may be completed through an educational program, under
						the personal charge of a preceptor, through a preapproved unconventional
						internship, or through an educational program outside of the United States
						under subrule (2) of this rule. An internship is subject to all of the
						following:
(a) Not more than 40 hours per week
						may be earned.
(b) An
						unconventional internship requires prior board approval and is limited to a
						maximum of 400 hours, with a maximum of 16 hours earned per week, and not more
						than 40 hours earned per week when the intern's pharmacy school is not in
						session. As used in this subdivision, "unconventional internship" means an
						educational program of professional and practical experience involving the
						pharmacy or related pharmaceutical experiences which, through on-the-job
						training, provides knowledge useful to the practice of the profession of
						pharmacy.
(c) The licensed pharmacy
						preceptor, an approved education program, or other individual previously
						approved by the board shall verify internship hours.
(d) An individual participating in a
						preapproved unconventional internship shall annually submit to the department
						an affidavit from the internship supervisor that includes the type of
						activities performed and the number of internship hours completed.
(e) The internship must provide professional
						and practical experience.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Pharmacy › Board of Pharmacy - General Rules › PHARMACY SERVICES IN MEDICAL INSTITUTIONS › Part 2 - PHARMACIST LICENSES › Section R. 338.517 - Preceptor license and responsibilities

Current through Vol. 24-12, July 15, 2024
Rule 17.
(1)
						An applicant for licensure as a pharmacist preceptor shall submit to the
						department a completed application on a form provided by the
						department.
(2) The applicant shall
						satisfy both of the following:
(a) Have an
						unrestricted pharmacist license from this state that is in good standing for
						the past year.
(b) Have been
						engaged in the practice of pharmacy in this state for at least 1
						year.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Pharmacy › Board of Pharmacy - General Rules › PHARMACY SERVICES IN MEDICAL INSTITUTIONS › Part 2 - PHARMACIST LICENSES › Section R. 338.519 - Examinations adoption; passing scores; reexamination

Current through Vol. 24-12, July 15, 2024
Rule 19.
(1)
						The board adopts the NAPLEX developed and administered by the NABP.
(2) The passing score for the NAPLEX accepted
						for licensure is the passing score established by the NABP.
(3) An applicant that fails to pass the
						NAPLEX shall wait not less than 45 days to retest or comply with the current
						waiting period established by NABP, whichever is longer. An applicant that has
						not achieved a passing score on the NAPLEX may not take the NAPLEX more than 3
						times in a 12-month period.
(4) If
						an applicant for licensure fails to pass the NAPLEX within 3 attempts, the
						applicant shall request preapproval from the department, after consultation
						with a board member, if necessary, of a live or interactive examination
						preparation course, or instruction with an instructor with expertise on the
						subject matter, for the examination that the applicant failed. After
						participating in the course or instruction the applicant shall provide the
						department with proof that the applicant completed the course or
						instruction.
(5) An applicant may
						not sit for the NAPLEX specified in subrule (4) of this rule more than 5 times,
						unless the applicant successfully repeats an approved education program, as
						specified in R
						338.521(2)(a)(i) and provides proof
						of completion to the department.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Pharmacy › Board of Pharmacy - General Rules › PHARMACY SERVICES IN MEDICAL INSTITUTIONS › Part 2 - PHARMACIST LICENSES › Section R. 338.521 - Pharmacist licensure by examination

Current through Vol. 24-12, July 15, 2024
Rule 21.
(1)
						An applicant for licensure as a pharmacist by examination shall submit to the
						department a completed application on a form provided by the department with
						the requisite fee.
(2) In addition
						to meeting the requirements of section 16174 of the code, MCL
						333.16174;
						R 338.7001 to
						R 338.7005; and any other rules
						promulgated under the code, an applicant for licensure shall satisfy all of the
						following requirements:
(a) Obtain one of the
						following:
(i) A professional degree from a
						school of pharmacy accredited by the ACPE.
(ii) A FPGEC certification from the NABP. An
						applicant that has an FPGEC certification from NABP has met the English
						proficiency requirement as the applicant's credentials and English proficiency
						have been evaluated and determined to be equivalent to the credentials required
						in this state.
(iii) A score
						transfer from NABP if the applicant has been licensed in another state for 1
						day to 1 year.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Pharmacy › Board of Pharmacy - General Rules › PHARMACY SERVICES IN MEDICAL INSTITUTIONS › Part 2 - PHARMACIST LICENSES › Section R. 338.523 - Pharmacist license by endorsement; requirements

Current through Vol. 24-12, July 15, 2024
Rule 23.
(1)
						An applicant that has never held a pharmacist license in this state and is
						licensed in another state or Canada, may apply for licensure as a pharmacist by
						endorsement by submitting to the department a completed application on a form
						provided by the department with the requisite fee. An applicant that meets the
						requirements of this rule,
						R 338.7001 to
						R 338.7005, and any other rules
						promulgated under the code is presumed to meet the requirements of section
						16186 of the code, MCL
						333.16186.
(2) An applicant shall satisfy all of the
						following requirements:
(a) Establish 1 of the
						following:
(i) The applicant holds a license
						in good standing as a pharmacist in another state and submits the NABP
						licensure transfer report to the department.
(ii) The applicant holds a pharmacy license
						in Canada that is in good standing and meets all of the following:
(A) The applicant has passed the NAPLEX or
						both part I and part II of the Pharmacy Examining Board of Canada Pharmacists
						Qualifying Examination.
(B) The
						applicant completed educational requirements for a pharmacist license from a
						school of pharmacy accredited by the ACPE or accredited by the Canadian Council
						for Accreditation of Pharmacy Programs.
(C) If the applicant held a pharmacist
						license for less than 1 year in Canada, the applicant had acquired a minimum of
						1,600 hours of pharmacy practice either through an approved internship or hours
						engaged in the practice as a pharmacist.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Pharmacy › Board of Pharmacy - General Rules › PHARMACY SERVICES IN MEDICAL INSTITUTIONS › Part 3 - PHARMACY LICENSES › Section R. 338.531a - Remote pharmacy waiver from mileage requirement

Current through Vol. 24-12, July 15, 2024
Rule 31a.
(1)
						An applicant seeking a remote pharmacy license may apply to the board for a
						waiver from the prohibition of locating a remote pharmacy within 10 miles of
						another pharmacy in section 17742a(2)(c) of the code, MCL
						333.17742a, by submitting a
						completed application to the department, on a form provided by the
						department.
(2) The applicant shall
						submit the following with the application:
(a)
						A map showing the location of any existing pharmacies within 10 miles of the
						proposed remote pharmacy if the remote pharmacy will not be located at a
						hospital or mental health facility.
(b) A list and explanation of the services or
						availability of services that will be offered at the remote pharmacy or
						otherwise not readily available to patients that are different from the
						services offered at a pharmacy located within 10 miles of the proposed remote
						pharmacy.
(c) A statement of facts
						to support the statement of 1 or more of the following:
(i) The proposed remote pharmacy is located
						in an area where there is limited access to pharmacy services.
(ii) The proposed remote pharmacy will offer
						a service or the availability of a service that is unique from other pharmacies
						in the 10-mile radius from the remote pharmacy and the service will satisfy an
						unmet need of the surrounding community.
(iii) There exists a limitation on travel
						that justifies waiving the requirement.
(iv) There are other compelling circumstances
						that justify waiving the requirement.
Michigan Administrative Code › Department - Licensing and Regulatory Affairs › Bureau of Professional Licensing › Board of Pharmacy › Board of Pharmacy - General Rules › PHARMACY SERVICES IN MEDICAL INSTITUTIONS › Part 3 - PHARMACY LICENSES › Section R. 338.532 - Sterile compounding accrediting organizations; board approval; inspection entities

Current through Vol. 24-12, July 15, 2024
Rule 32.
(1)
						The board shall approve, under section 17748a of the code, MCL
						333.17748a, accrediting
						organizations or inspection entities for pharmacies that compound
						pharmaceuticals according to standards adopted by reference in
						R 338.533.
(2) The department shall post on its website,
						the list of organizations approved under subrule (1) of this rule.
(3) An organization may petition the board
						for approval under subrule (1) of this rule. The petition must include, but is
						not limited to, all of the following:
(a)
						Requirements for accreditation or compliance.
(b) Requirements for inspectors.
(c) Training provided to
						inspectors.
(d) Copy of the most
						current inspection form.
(e) The
						length of accreditation.
(f)
						Agreement and plan to share results of inspections with the
						department.